Showing results (31-40 of 421) with videos related to
Sort By:
Pageof 43
Chemical Immunology|January 1, 1990
Anti-idiotypic therapy of leukemias and lymphomasF K Stevenson, A J George, M J GlennieImmunology|April 1, 1977
Some effects on leukaemic B lymphocytes of antibodies to defined regions of their surface immunoglobulinF K Stevenson, E V Elliott, G T StevensonMolecular Immunology|July 1, 1991
Characterisation of a light chain loss variant of the BCL1 lymphomaA J George, R C Foreman, F K StevensonJournal of Immunology (Baltimore, Md. : 1950)|January 15, 1987
Anti-idiotypic mechanisms involved in suppression of a mouse B cell lymphoma, BCL1A J George, A L Tutt, F K StevensonLeukemia|August 1, 1994
Assessment of the role of clonogenic B lymphocytes in the pathogenesis of multiple myelomaS Sahota, T Hamblin, D G Oscier, et al.Blood|June 1, 1997
Differential rates of somatic hypermutation in V(H) genes among subsets of chronic lymphocytic leukemia defined by chromosomal abnormalitiesD G Oscier, A Thompsett, D Zhu, et al.Current Cancer Drug Targets|September 22, 2011
Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignanciesK Podar, K C AndersonThe Oncologist|May 2, 2001
History of the development of arsenic derivatives in cancer therapyS Waxman, K C AndersonApoptosis : an International Journal on Programmed Cell Death|April 26, 2001
Apoptosis in multiple myeloma: therapeutic implicationsD Chauhan, K C AndersonLeukemia|July 23, 2013
Association of response endpoints with survival outcomes in multiple myelomaS Lonial, K C AndersonPageof 43